Sat, Aug 23, 2014, 2:43 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • tradersoracle tradersoracle Mar 1, 2013 1:17 PM Flag

    Clarification of Phase III Ampion trial

    The 8k announced this morning states that once the Ampion IND is accepted which is expected to be fairly soon because it is based on the FDA's recommendations, the Phase III trial will commence.

    There will be two trials of 800 patients each.

    One of the trials will include 320 patients and has the possibility of substantially reducing the number from 800 that will most likely result in significant cost and time savings.

    This announcement enhances the phase III trial and does not protract the time or add to the cost.

    The reason for the 320 patient run-in study is to evaluate Ampion's performance if it is increased from 4 ml to a more common dose currently used for Synvisc or steroid injections.

    The CRO who ran the phase II trial for Ampion says that results from the 4ml injections were the best results of any drug they ever performed trials of in their 25 year history. Ampion was effective in hours, not in the 84 days as some suggest based on the company's presentation indicating the 84 days that is misleading.

    The company is now waiting for the FDA's acceptance of their recently filed new IND.

    Hope this clarifies.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • " Ampion was effective in hours, not in the 84 days as some suggest based on the company's presentation indicating the 84 days that is misleading."

      Really Rich, how is this misleading? Look at the company data and explain how the data before day 84 are statistically significant? The numbers are very clear and don't lie.

      How's it going with getting the IR job at AMPE? They call you back yet?

 
AMPE
4.84-0.82(-14.49%)Aug 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.